Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer.

about

Crosstalk between M2 macrophages and glioma stem cells.Live kinase B1 maintains CD34+CD38- AML cell proliferation and self-renewal.

P2860

Q53735490-3F48EF97-A175-47D2-A9DE-99A960458A22 Q53744298-5EF56FDF-46CC-44A7-8455-6DDA77EF1D31

P2860

Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer.

Item

http://www.wikidata.org/entity/Q52846906

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Novel strategies for targeting ...... death knell for blood cancer.

@en

Novel strategies for targeting ...... death knell for blood cancer.

@nl

type

Item

label

Novel strategies for targeting ...... death knell for blood cancer.

@en

Novel strategies for targeting ...... death knell for blood cancer.

@nl

prefLabel

Novel strategies for targeting ...... death knell for blood cancer.

@en

Novel strategies for targeting ...... death knell for blood cancer.

@nl

P1476

Novel strategies for targeting ...... death knell for blood cancer.

@en

P2093

Antonieta Chavez-Gonzalez

http://www.w3.org/2001/XMLSchema#string

Babak Bakhshinejad

http://www.w3.org/2001/XMLSchema#string

Katayoon Pakravan

http://www.w3.org/2001/XMLSchema#string

Monica L Guzman

http://www.w3.org/2001/XMLSchema#string

Sadegh Babashah

http://www.w3.org/2001/XMLSchema#string

P2860

Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia

Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells

A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activity

P2888

s13402-016-0297-1

P304

1-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13402-016-0297-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27678246

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

5842429

http://www.w3.org/2001/XMLSchema#string

Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer.

about

P2860

P2860

Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932